Dr. Emmanuel Fombu and Pek Lum Ph.D.

Dr. Emmanuel Fombu is an internationally recognized authority on the convergence of digital technologies and healthcare. He is an award-winning and best-selling author, physician, Keynote speaker, investor, entrepreneur, and medical futurist with over 15 years of combined experience in science, research, and healthcare. Dr. Fombu did his clinical training at Emory-Crawford Long Hospital and holds an MBA from both Cornell University’s Johnson School of Business and Queen’s University’s Smith School of Business. He also earned a certification in Artificial Intelligence: Implications for Business Strategy from MIT’s Sloan School of Management and Computer Science Artificial Intelligence Lab. Dr. Fombu has authored multiple research papers and abstracts in renowned peer-reviewed journals. He serves as an external advisory board member at the Massachusetts Institute of Technology’s MIT.nano project. He lives in New York City.

Pek Lum, Co-founder and CEO at Auransa. With more than 20 years of genomics and drug discovery experience, she is the chief architect of the science behind Auransa’s technology. Before founding Auransa, Pek was vice president of Product and chief data scientist for Ayasdi. Pek started off her career at Rosetta Inpharmatics, a pioneer in genomics and microarray technology. Pek received her Ph.D. in yeast genetics at the University of Washington, Seattle. Her work has been published in scientific journals, such as Nature and Cell, and her research has contributed to discoveries in drug development and the understanding of complex diseases. She has previously served as an advisor to the Michael J. Fox Foundation for Parkinson’s Research, Bayes Impact and Resolution Bioscience, and is currently an advisor for Sequence Bio.